Status:
TERMINATED
Honey in Chronic Immune Thrombocytopenia
Lead Sponsor:
mamdouh abdulmaksoud abdulrhman
Conditions:
Chronic Thrombocytopenic Purpura
Eligibility:
All Genders
5-15 years
Brief Summary
Based on the assumption that honey may have an immunomodulatory effect, the aim of our present study will be to verify whether the intake of honey, as a natural substance, in patients with chronic Imm...
Detailed Description
Study design: A crossover design (two 12-weeks intervention periods) will be used to measure treatment effects. The subjects will be randomized into two groups (intervention to control \[I/C\] and co...
Eligibility Criteria
Inclusion
- Patients with chronic ITP who did not receive any treatment specific for ITP within the past 3 months
- Who did not receive bee honey or any medication that may affect platelet number or function within the past 3 months and
- In whom the bleeding severity will range from 1 to 3 (mild to moderate bleeding) according to Buchanan and Adix (2002).
Exclusion
- Grade 4 bleeding severity, according Buchanan and Adix (2002) and
- Presence of diabetes mellitus.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01462916
Start Date
October 1 2014
End Date
December 1 2017
Last Update
January 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Department, Faculty of Medicine, Ain Shams University
Cairo, Egypt